The prevalence of alloimmunization varies based on the population and the underlying conditions. It is more common in populations requiring frequent transfusions, such as those with sickle cell disease. Epidemiological studies help identify at-risk populations and develop targeted prevention and management strategies. Data collection and analysis are crucial for understanding the incidence, risk factors, and outcomes associated with alloimmunization.